Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Original Research

Epigenetic Regulation of Adipogenesis by PHF2 Histone Demethylase

  1. Yosuke Okuno1,
  2. Fumiaki Ohtake1,
  3. Katsuhide Igarashi2,
  4. Jun Kanno2,
  5. Takahiro Matsumoto1,
  6. Ichiro Takada1,
  7. Shigeaki Kato3 and
  8. Yuuki Imai1⇑
  1. 1Laboratory of Epigenetic Skeletal Diseases, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, Japan
  2. 2Division of Cellular and Molecular Toxicology, National Institute of Health Sciences, Tokyo, Japan
  3. 3Soma Central Hospital, Soma, Japan
  1. Corresponding author: Yuuki Imai, yimai{at}iam.u-tokyo.ac.jp.
Diabetes 2013 May; 62(5): 1426-1434. https://doi.org/10.2337/db12-0628
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Strategic scheme for targeted disruption of mouse Phf2. A: Targeting strategy with positive/negative selection. Strategy of genomic Southern blotting in the screening for homologous recombinant embryonic stem cell clones is also included. E5, E6, and E7 represent exon 5, exon 6, and exon 7 of Phf2, respectively. B, H, E, and N represent BglII, HindIII, EcoRI, and NsiI cut sites, respectively. P1, P2, P3, P4, and P5 represent locations of primers used in C and D. Embedded Image, the LoxP sites; Embedded Image, Frt sites. B: Southern blotting analysis of targeted embryonic stem cell clones. Restriction enzymes used for screening recombination events with probe A were BglII and HindIII. An 8.3-kb fragment in WT and a 5.3-kb fragment after homologous recombination were expected with probe A. Restriction enzymes used for screening recombination events with probe B were EcoRI and NsiI. A 9.0-kb fragment in WT and a 7.2-kb fragment after homologous recombination were expected with probe B. C: To detect the presence of the LacZ allele (Z) and the WT allele (+), primers P1, P2, and P3 were used. The PCR bands of the WT allele (242 bp) and the LacZ allele (495 bp) are indicated. D: To detect the presence of the floxed allele (fl) and the WT allele (+), primers P4 and P5 were used. The PCR bands of the WT allele (162 bp) and the floxed allele (245 bp) are indicated. E: Western blot analysis of PHF2 protein expression in Phf2Z/Z mice. Extracts of mouse embryonic fibroblasts from WT or Phf2Z/Z were immunoprecipitated and detected with anti-PHF2 antibody. WT, wild type.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Physiological features of systemic Phf2 knockout mice. A: Genotypes of progeny of crosses between Phf2Z/+ at birth. B: Genotypes of progeny of crosses between Phf2Z/+ at 2 weeks of age. C: Survival rate of progeny of crosses between Phf2Z/+. D: Growth curves of wild-type, heterozygous, and homozygous Phf2 knockout mice until 10 days after birth. E: Growth curves of male mice and female mice of indicated genotypes between 2 and 10 weeks of age. ◇, wild-type mice (+/+); ■, heterozygous Phf2 knockout mice (Z/+); ▲, homozygous Phf2 knockout mice (Z/Z). *P < 0.05; **P < 0.01 compared with wild type.

  • FIG. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Assessment of adipose tissue of systemic Phf2 knockout mice. A: Ratio of body weight and nasoanal length or normalized tissue weight of male Phf2Z/Z to WT littermates at 5 weeks of age. Tissue weights were normalized to body weights (n = 6). B: Weights of epididymal (epi) WAT, subcutaneous (sub) WAT, and mesenteric (mes) WAT of male Phf2Z/Z KO mice and WT littermates at 5 weeks of age (n = 3). C: Weights of gonadal WAT of female Phf2Z/Z KO mice and WT littermates at 5 weeks of age (n = 4). D: Mean adipocyte areas of epididymal WAT from Phf2Z/Z KO mice and WT littermates (n = 5). High-magnification micrographs of WAT are shown. E: Adipocyte number in epididymal fat pads of Phf2Z/Z KO mice and WT littermates (n = 7). F: Real-time qPCR analysis of adipocyte marker genes and Phf2 of Phf2Z/Z KO mice and WT littermates (n = 3). *P < 0.05; **P < 0.01 compared with WT. KO, knockout; WT, wild type. (A high-quality color representation of this figure is available in the online issue.)

  • FIG. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Effects of PHF2 knock down on adipogenesis. A–C: SVCs from Cre-ERT2; Phf2fl/fl (fl/fl) or Cre-ERT2 (+/+) were treated with or without 4-OHT and differentiated into adipocytes by treatment with insulin, dexamethasone, and isobutylmethylxanthine. Image (A) and quantification (B) of oil red O staining and the results of real-time qPCR analysis of adipocyte marker genes (C) are shown (n = 3). D–F: 3T3-L1 cells infected with retroviruses containing either pSuper-retro-shLacZ or pSuper-retro-shPHF2 were differentiated into adipocytes. Image (D) and quantification (E) of oil red O staining and the results of real-time qPCR analysis of adipocyte marker genes (F) are shown (n = 3). *P < 0.05; **P < 0.01 compared with control.

  • FIG. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Association of PHF2 with CEBPA. A: FLAG-CEBPA or FLAG-PPARG was transfected into HEK293T cells. Cells were harvested and immunoprecipitated with anti-FLAG antibody and detected with anti-PHF2 antibody or anti-FLAG antibody. B: FLAG-PHF2 was transfected into 3T3-L1 adipocytes. Cells were harvested and immunoprecipitated with anti-FLAG antibody and detected with anti-CEBPA antibody or anti-FLAG antibody. C: 3T3-L1 cells were fixed in formaldehyde on day 4 after differentiation, after which chromatin samples were subjected to ChIP analysis with indicated antibodies and amplified with primers toward indicated loci (n = 3). D and E: 3T3-L1 cells stably transfected with pSuper-retro-shLacZ or pSuper-retro-shPHF2 were differentiated into adipocytes and subjected to ChIP analysis with anti-CEBPA (D) or anti-H3K9me2 antibody (E), with primers toward the indicated loci (n = 3). *P < 0.05; **P < 0.01 compared with control. NC, negative control region.

PreviousNext
Back to top
Diabetes: 62 (5)

In this Issue

May 2013, 62(5)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Epigenetic Regulation of Adipogenesis by PHF2 Histone Demethylase
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Epigenetic Regulation of Adipogenesis by PHF2 Histone Demethylase
Yosuke Okuno, Fumiaki Ohtake, Katsuhide Igarashi, Jun Kanno, Takahiro Matsumoto, Ichiro Takada, Shigeaki Kato, Yuuki Imai
Diabetes May 2013, 62 (5) 1426-1434; DOI: 10.2337/db12-0628

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Epigenetic Regulation of Adipogenesis by PHF2 Histone Demethylase
Yosuke Okuno, Fumiaki Ohtake, Katsuhide Igarashi, Jun Kanno, Takahiro Matsumoto, Ichiro Takada, Shigeaki Kato, Yuuki Imai
Diabetes May 2013, 62 (5) 1426-1434; DOI: 10.2337/db12-0628
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Original Research

  • A transcription start site map in human pancreatic islets reveals functional regulatory signatures
  • DNA methylation GrimAge and Incident Diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
  • Overexpression of Nrf2 in Renal Proximal Tubular Cells Stimulates Sodium-Glucose Co-Transporter 2 Expression and Exacerbates Dysglycemia and Kidney Injury in Diabetic Mice
Show more Original Research

Metabolism

  • Ncor2/PPARα-Dependent Upregulation of MCUb in the Type 2 Diabetic Heart Impacts Cardiac Metabolic Flexibility and Function
  • Role of the Neutral Amino Acid Transporter SLC7A10 in Adipocyte Lipid Storage, Obesity, and Insulin Resistance
  • Heme Oxygenase-1 Regulates Ferrous Iron and Foxo1 in Control of Hepatic Gluconeogenesis
Show more Metabolism

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.